Small Molecules, Generics
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,724
NCT02378194
Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2010
Completion: Mar 31, 2013
NCT01723891
Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers
Phase: Phase 1
Start: Nov 30, 2012
Completion: Not specified
NCT02395913
Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg)
Start: Jul 31, 2013
Completion: Sep 30, 2013
NCT01863810
Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain
Phase: Phase 3
Start: Aug 31, 2013
Completion: Oct 31, 2014
NCT02395926
To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers
Start: Oct 31, 2013
Completion: Dec 31, 2013
NCT02373891
Study to Evaluate the Effect of Food on the Pharmacokinetics of Surfolase CR Tablet in Healthy Volunteers
Start: Apr 30, 2014
Completion: Jul 31, 2014
NCT02792946
Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis
Start: Nov 30, 2015
Completion: Jan 31, 2016
NCT03234244
HDDO-1614 Intervention Trial
Start: Apr 12, 2017
Completion: Aug 14, 2017
NCT03382314
HDDO-1614 Bio Equivalence Study
Start: Oct 16, 2017
Completion: Jan 5, 2018
NCT04097951
HDDO-1801 Intervention Trial
Start: Nov 8, 2019
Completion: Feb 28, 2020
NCT04229927
BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease
Start: Feb 27, 2020
Completion: Mar 1, 2023
NCT04755894
HDDO-1756 Bio Equivalence Study
Start: Jun 12, 2020
Completion: Jul 27, 2020
Loading map...